(Q39321112)

11 September 2017

Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis (English)

1 reference

11 September 2017

0 references

V Balasubramanian

1

1 reference

11 September 2017

S Solapure

2

1 reference

11 September 2017

H Iyer

3

1 reference

11 September 2017

A Ghosh

4

1 reference

11 September 2017

S Sharma

5

1 reference

11 September 2017

P Kaur

6

1 reference

11 September 2017

R Deepthi

7

1 reference

11 September 2017

V Subbulakshmi

8

1 reference

11 September 2017

V Ramya

9

1 reference

11 September 2017

V Ramachandran

10

1 reference

11 September 2017

M Balganesh

11

1 reference

11 September 2017

L Wright

12

1 reference

11 September 2017

D Melnick

13

1 reference

11 September 2017

S L Butler

14

1 reference

11 September 2017

V K Sambandamurthy

15

1 reference

11 September 2017

language of work or name

English

0 references

publication date

4 November 2013

1 reference

Antimicrobial Agents and Chemotherapy

11 September 2017

1 reference

11 September 2017

58

1 reference

11 September 2017

1

1 reference

11 September 2017

495-502

1 reference

In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Linezolid for treatment of chronic extensively drug-resistant tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Advancing the development of tuberculosis therapy

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

The oxazolidinones: past, present, and future.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

The population dynamics and control of tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Mechanism-based pharmacokinetic-pharmacodynamic modeling of antimicrobial drug effects

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Linezolid for the treatment of multidrug-resistant tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910779

21 August 2018

Identifiers

DOI

10.1128/AAC.01903-13

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

24189255

1 reference